Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson’s disease
暂无分享,去创建一个
G. Fink | V. Visser-Vandewalle | L. Timmermann | R. Martinez | K. Ashkan | M. Barbe | E. Fonoff | P. Martínez-Martín | A. Antonini | R. Cury | H. Dafsari | K. Ray-Chaudhuri | A. Rizos | M. Silverdale | Julian Evans | S. Jost | Maria Gabriela Ghilardi | J. Evans | M. G. Ghilardi
[1] G. Fink,et al. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] V. Visser-Vandewalle,et al. Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms , 2020, Annals of neurology.
[3] R. Uitti,et al. Globus Pallidus Externus Deep Brain Stimulation Treats Insomnia in a Patient With Parkinson Disease. , 2020, Mayo Clinic proceedings.
[4] M. Husain. Targeting network dysfunction in neurodegenerative diseases. , 2019, Brain : a journal of neurology.
[5] Marios Politis,et al. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease. , 2019, Brain : a journal of neurology.
[6] Alejandro Osorio-Forero,et al. Regulation of Local Sleep by the Thalamic Reticular Nucleus , 2019, Front. Neurosci..
[7] G. Fink,et al. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.
[8] G. Fink,et al. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease , 2018, European journal of neurology.
[9] M. Muthuraman,et al. Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's Disease , 2018, Front. Neurol..
[10] V. Visser-Vandewalle,et al. Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease , 2018, Neuromodulation : journal of the International Neuromodulation Society.
[11] G. Fink,et al. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts , 2018, Brain Stimulation.
[12] V. Visser-Vandewalle,et al. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease , 2018, Brain Stimulation.
[13] E. Fonoff,et al. Effects of Subthalamic Stimulation on Olfactory Function in Parkinson Disease. , 2018, World neurosurgery.
[14] Anand I. Rughani,et al. Congress of Neurological Surgeons Systematic Review and Evidence‐Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary , 2018, Neurosurgery.
[15] M. Okun,et al. Segmentation of the Globus Pallidus Internus Using Probabilistic Diffusion Tractography for Deep Brain Stimulation Targeting in Parkinson Disease , 2018, American Journal of Neuroradiology.
[16] J. Ostrem,et al. Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: A Review , 2018, JAMA neurology.
[17] V. Visser-Vandewalle,et al. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.
[18] R. D. de Bie,et al. Does deep brain stimulation improve lower urinary tract symptoms in Parkinson's disease? , 2018, Neurourology and urodynamics.
[19] Lars Timmermann,et al. Directional DBS increases side‐effect thresholds—A prospective, double‐blind trial , 2017, Movement disorders : official journal of the Movement Disorder Society.
[20] M. Politis,et al. Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis? , 2017, npj Parkinson's Disease.
[21] M. Kurtis,et al. The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence , 2017, npj Parkinson's Disease.
[22] Bogdan Draganski,et al. Brain networks modulated by subthalamic nucleus deep brain stimulation. , 2016, Brain : a journal of neurology.
[23] Qian Zhou,et al. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson’s disease: a meta-analysis of randomized controlled trials , 2016, Clinical interventions in aging.
[24] R. Dmochowski,et al. The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease , 2016, Neuromodulation : journal of the International Neuromodulation Society.
[25] B. Shao,et al. Effects of neurostimulation for advanced Parkinson’s disease patients on motor symptoms: A multiple-treatments meta-analysas of randomized controlled trials , 2016, Scientific Reports.
[26] S. Farias,et al. Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's Disease , 2015, Chinese medical journal.
[27] Ying Luo,et al. [Propensity score matching in SPSS]. , 2015, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[28] A. Lang,et al. Parkinson's disease , 2015, The Lancet.
[29] P. Svenningsson,et al. EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[30] E. Fonoff,et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease , 2014, Neurology.
[31] M. Okun,et al. Subthalamic Nucleus Versus Globus Pallidus Internus Deep Brain Stimulation: Translating the Rematch Into Clinical Practice , 2014 .
[32] M. T. Barbe,et al. Modulation of local field potential power of the subthalamic nucleus during isometric force generation in patients with Parkinson’s disease , 2013, Neuroscience.
[33] Alessandro Stefani,et al. The Serendipity Case of the Pedunculopontine Nucleus Low-Frequency Brain Stimulation: Chasing a Gait Response, Finding Sleep, and Cognition Improvement , 2013, Front. Neurol..
[34] H. Reichmann,et al. Nonmotor fluctuations in Parkinson disease , 2013, Neurology.
[35] L. Bour,et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial , 2013, The Lancet Neurology.
[36] James Carpenter,et al. Propensity scores: From naïve enthusiasm to intuitive understanding , 2012, Statistical methods in medical research.
[37] R. Sakakibara,et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. , 2012, Brain : a journal of neurology.
[38] Anette Schrag,et al. Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations , 2011, Movement disorders : official journal of the Movement Disorder Society.
[39] R. Hauser,et al. Determination of minimal clinically important change in early and advanced Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[40] K. Chaudhuri,et al. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[41] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[42] P. Krack,et al. Deep brain stimulation: from neurology to psychiatry? , 2010, Trends in Neurosciences.
[43] Grant D. Huang,et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.
[44] M. C. Campbell,et al. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease , 2008, Neuropsychologia.
[45] C. Moreau,et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease , 2008, Neurology.
[46] Adrian Danek,et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study , 2008, The Lancet Neurology.
[47] Paolo Barone,et al. The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.
[48] G. Deuschl,et al. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. , 2006, Brain : a journal of neurology.
[49] G. Deuschl,et al. A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.
[50] G. Deuschl,et al. Deep Brain Stimulation in Parkinson's Disease , 2018, Parkinson's disease.
[51] H. Reichmann,et al. Olfactory function in patients with idiopathic Parkinson’s disease: effects of deep brain stimulation in the subthalamic nucleus , 2005, Journal of Neural Transmission.
[52] Michael S Okun,et al. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? , 2005, Archives of neurology.
[53] J. Paul Bolam,et al. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? , 2004, Trends in Neurosciences.
[54] A. Benabid,et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.
[55] E. Tolosa,et al. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation , 2002, Journal of neurology, neurosurgery, and psychiatry.
[56] Michael Smithson,et al. Correct Confidence Intervals for Various Regression Effect Sizes and Parameters: The Importance of Noncentral Distributions in Computing Intervals , 2001 .
[57] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[58] Donald B. Rubin,et al. BEST PRACTICES IN QUASI- EXPERIMENTAL DESIGNS Matching Methods for Causal Inference , 2007 .
[59] R. Fitzpatrick,et al. The PDQ-8: Development and validation of a short-form parkinson's disease questionnaire , 1997 .
[60] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .